<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d328" origId="Enoxacin"><sentence id="DrugDDI.d328.s0" origId="s0" text="Bismuth: Bismuth subsalicylate, given concomitantly with enoxacin or 60 minutes following enoxacin administration, decreased enoxacin bioavailability by approximately 25%."><entity id="DrugDDI.d328.s0.e0" origId="s0.p2" charOffset="9-30" type="drug" text="Bismuth subsalicylate"/><entity id="DrugDDI.d328.s0.e1" origId="s0.p5" charOffset="57-65" type="drug" text="enoxacin"/><entity id="DrugDDI.d328.s0.e2" origId="s0.p9" charOffset="90-98" type="drug" text="enoxacin"/><entity id="DrugDDI.d328.s0.e3" origId="s0.p10" charOffset="125-133" type="drug" text="enoxacin"/><pair id="DrugDDI.d328.s0.p0" e1="DrugDDI.d328.s0.e0" e2="DrugDDI.d328.s0.e1" interaction="true"/><pair id="DrugDDI.d328.s0.p1" e1="DrugDDI.d328.s0.e0" e2="DrugDDI.d328.s0.e2" interaction="false"/><pair id="DrugDDI.d328.s0.p2" e1="DrugDDI.d328.s0.e0" e2="DrugDDI.d328.s0.e3" interaction="false"/><pair id="DrugDDI.d328.s0.p3" e1="DrugDDI.d328.s0.e1" e2="DrugDDI.d328.s0.e2" interaction="false"/><pair id="DrugDDI.d328.s0.p4" e1="DrugDDI.d328.s0.e1" e2="DrugDDI.d328.s0.e3" interaction="false"/><pair id="DrugDDI.d328.s0.p5" e1="DrugDDI.d328.s0.e2" e2="DrugDDI.d328.s0.e3" interaction="false"/></sentence><sentence id="DrugDDI.d328.s1" origId="s1" text="Thus, concomitant administration of enoxacin and bismuth subsalicylate should be avoided."><entity id="DrugDDI.d328.s1.e0" origId="s1.p14" charOffset="36-44" type="drug" text="enoxacin"/><entity id="DrugDDI.d328.s1.e1" origId="s1.p16" charOffset="49-70" type="drug" text="bismuth subsalicylate"/><pair id="DrugDDI.d328.s1.p0" e1="DrugDDI.d328.s1.e0" e2="DrugDDI.d328.s1.e1" interaction="true"/></sentence><sentence id="DrugDDI.d328.s2" origId="s2" text="Caffeine: Enoxacin is a potent inhibitor of the cytochrome P-450 isozymes responsible for the metabolism of methylxanthines."><entity id="DrugDDI.d328.s2.e0" origId="s2.p20" charOffset="0-8" type="drug" text="Caffeine"/><entity id="DrugDDI.d328.s2.e1" origId="s2.p22" charOffset="10-18" type="drug" text="Enoxacin"/><entity id="DrugDDI.d328.s2.e2" origId="s2.p25" charOffset="48-64" type="drug" text="cytochrome P-450"/><entity id="DrugDDI.d328.s2.e3" origId="s2.p27" charOffset="108-123" type="drug" text="methylxanthines"/><pair id="DrugDDI.d328.s2.p0" e1="DrugDDI.d328.s2.e0" e2="DrugDDI.d328.s2.e1" interaction="false"/><pair id="DrugDDI.d328.s2.p1" e1="DrugDDI.d328.s2.e0" e2="DrugDDI.d328.s2.e2" interaction="false"/><pair id="DrugDDI.d328.s2.p2" e1="DrugDDI.d328.s2.e0" e2="DrugDDI.d328.s2.e3" interaction="false"/><pair id="DrugDDI.d328.s2.p3" e1="DrugDDI.d328.s2.e1" e2="DrugDDI.d328.s2.e2" interaction="false"/><pair id="DrugDDI.d328.s2.p4" e1="DrugDDI.d328.s2.e1" e2="DrugDDI.d328.s2.e3" interaction="false"/><pair id="DrugDDI.d328.s2.p5" e1="DrugDDI.d328.s2.e2" e2="DrugDDI.d328.s2.e3" interaction="false"/></sentence><sentence id="DrugDDI.d328.s3" origId="s3" text="In a multiple-dose study, enoxacin caused a dose-related increase in the mean elimination half-life of caffeine, thereby decreasing the clearance of caffeine by up to 80% and leading to a five-fold increase in the AUC and the half-life of caffeine."><entity id="DrugDDI.d328.s3.e0" origId="s3.p29" charOffset="26-34" type="drug" text="enoxacin"/><entity id="DrugDDI.d328.s3.e1" origId="s3.p33" charOffset="103-111" type="drug" text="caffeine"/><entity id="DrugDDI.d328.s3.e2" origId="s3.p37" charOffset="149-157" type="drug" text="caffeine"/><entity id="DrugDDI.d328.s3.e3" origId="s3.p46" charOffset="239-247" type="drug" text="caffeine"/><pair id="DrugDDI.d328.s3.p0" e1="DrugDDI.d328.s3.e0" e2="DrugDDI.d328.s3.e1" interaction="true"/><pair id="DrugDDI.d328.s3.p1" e1="DrugDDI.d328.s3.e0" e2="DrugDDI.d328.s3.e2" interaction="false"/><pair id="DrugDDI.d328.s3.p2" e1="DrugDDI.d328.s3.e0" e2="DrugDDI.d328.s3.e3" interaction="false"/><pair id="DrugDDI.d328.s3.p3" e1="DrugDDI.d328.s3.e1" e2="DrugDDI.d328.s3.e2" interaction="false"/><pair id="DrugDDI.d328.s3.p4" e1="DrugDDI.d328.s3.e1" e2="DrugDDI.d328.s3.e3" interaction="false"/><pair id="DrugDDI.d328.s3.p5" e1="DrugDDI.d328.s3.e2" e2="DrugDDI.d328.s3.e3" interaction="false"/></sentence><sentence id="DrugDDI.d328.s4" origId="s4" text="Trough plasma enoxacin levels were also 20% higher when caffeine and enoxacin were administered concomitantly."><entity id="DrugDDI.d328.s4.e0" origId="s4.p47" charOffset="14-22" type="drug" text="enoxacin"/><entity id="DrugDDI.d328.s4.e1" origId="s4.p51" charOffset="56-64" type="drug" text="caffeine"/><entity id="DrugDDI.d328.s4.e2" origId="s4.p53" charOffset="69-77" type="drug" text="enoxacin"/><pair id="DrugDDI.d328.s4.p0" e1="DrugDDI.d328.s4.e0" e2="DrugDDI.d328.s4.e1" interaction="false"/><pair id="DrugDDI.d328.s4.p1" e1="DrugDDI.d328.s4.e0" e2="DrugDDI.d328.s4.e2" interaction="false"/><pair id="DrugDDI.d328.s4.p2" e1="DrugDDI.d328.s4.e1" e2="DrugDDI.d328.s4.e2" interaction="true"/></sentence><sentence id="DrugDDI.d328.s5" origId="s5" text="Caffeine-related adverse effects have occurred in patients consuming caffeine while on therapy with enoxacin."><entity id="DrugDDI.d328.s5.e0" origId="s5.p57" charOffset="0-8" type="drug" text="Caffeine"/><entity id="DrugDDI.d328.s5.e1" origId="s5.p62" charOffset="69-77" type="drug" text="caffeine"/><entity id="DrugDDI.d328.s5.e2" origId="s5.p65" charOffset="100-108" type="drug" text="enoxacin"/><pair id="DrugDDI.d328.s5.p0" e1="DrugDDI.d328.s5.e0" e2="DrugDDI.d328.s5.e1" interaction="false"/><pair id="DrugDDI.d328.s5.p1" e1="DrugDDI.d328.s5.e0" e2="DrugDDI.d328.s5.e2" interaction="false"/><pair id="DrugDDI.d328.s5.p2" e1="DrugDDI.d328.s5.e1" e2="DrugDDI.d328.s5.e2" interaction="true"/></sentence><sentence id="DrugDDI.d328.s6" origId="s6" text="Cyclosporine: Elevated serum levels of cyclosporine have been reported with concomitant use of cyclosporine with other members of the quinolone class."><entity id="DrugDDI.d328.s6.e0" origId="s6.p66" charOffset="0-12" type="drug" text="Cyclosporine"/><entity id="DrugDDI.d328.s6.e1" origId="s6.p69" charOffset="39-51" type="drug" text="cyclosporine"/><entity id="DrugDDI.d328.s6.e2" origId="s6.p74" charOffset="95-107" type="drug" text="cyclosporine"/><entity id="DrugDDI.d328.s6.e3" origId="s6.p76" charOffset="134-150" type="drug" text="quinolone class"/><pair id="DrugDDI.d328.s6.p0" e1="DrugDDI.d328.s6.e0" e2="DrugDDI.d328.s6.e1" interaction="false"/><pair id="DrugDDI.d328.s6.p1" e1="DrugDDI.d328.s6.e0" e2="DrugDDI.d328.s6.e2" interaction="false"/><pair id="DrugDDI.d328.s6.p2" e1="DrugDDI.d328.s6.e0" e2="DrugDDI.d328.s6.e3" interaction="false"/><pair id="DrugDDI.d328.s6.p3" e1="DrugDDI.d328.s6.e1" e2="DrugDDI.d328.s6.e2" interaction="false"/><pair id="DrugDDI.d328.s6.p4" e1="DrugDDI.d328.s6.e1" e2="DrugDDI.d328.s6.e3" interaction="false"/><pair id="DrugDDI.d328.s6.p5" e1="DrugDDI.d328.s6.e2" e2="DrugDDI.d328.s6.e3" interaction="true"/></sentence><sentence id="DrugDDI.d328.s7" origId="s7" text="Digoxin: Enoxacin may raise serum digoxin levels in some individuals."><entity id="DrugDDI.d328.s7.e0" origId="s7.p77" charOffset="0-7" type="drug" text="Digoxin"/><entity id="DrugDDI.d328.s7.e1" origId="s7.p79" charOffset="9-17" type="drug" text="Enoxacin"/><pair id="DrugDDI.d328.s7.p0" e1="DrugDDI.d328.s7.e0" e2="DrugDDI.d328.s7.e1" interaction="false"/></sentence><sentence id="DrugDDI.d328.s8" origId="s8" text="If signs and symptoms suggestive of digoxin toxicity occur when enoxacin and digoxin are given concomitantly, physicians are advised to obtain serum digoxin levels and adjust digoxin doses appropriately."><entity id="DrugDDI.d328.s8.e0" origId="s8.p90" charOffset="64-72" type="drug" text="enoxacin"/><entity id="DrugDDI.d328.s8.e1" origId="s8.p92" charOffset="77-84" type="drug" text="digoxin"/><pair id="DrugDDI.d328.s8.p0" e1="DrugDDI.d328.s8.e0" e2="DrugDDI.d328.s8.e1" interaction="true"/></sentence><sentence id="DrugDDI.d328.s9" origId="s9" text="Non-steroidal anti-inflammatory agents: Seizures have been reported in patients taking enoxacin concomitantly with the nonsteroidal anti-inflammatory drug fenbufen."><entity id="DrugDDI.d328.s9.e0" origId="s9.p104" charOffset="0-38" type="drug" text="non-steroidal anti-inflammatory agents"/><entity id="DrugDDI.d328.s9.e1" origId="s9.p112" charOffset="87-95" type="drug" text="enoxacin"/><entity id="DrugDDI.d328.s9.e2" origId="s9.p113" charOffset="119-154" type="drug" text="nonsteroidal anti-inflammatory drug"/><pair id="DrugDDI.d328.s9.p0" e1="DrugDDI.d328.s9.e0" e2="DrugDDI.d328.s9.e1" interaction="false"/><pair id="DrugDDI.d328.s9.p1" e1="DrugDDI.d328.s9.e0" e2="DrugDDI.d328.s9.e2" interaction="false"/><pair id="DrugDDI.d328.s9.p2" e1="DrugDDI.d328.s9.e1" e2="DrugDDI.d328.s9.e2" interaction="true"/></sentence><sentence id="DrugDDI.d328.s10" origId="s10" text="Animal studies also suggest an increased potential for seizures when these two drugs are given concomitantly."><entity id="DrugDDI.d328.s10.e0" origId="s10.p121" charOffset="79-84" type="drug" text="drugs"/></sentence><sentence id="DrugDDI.d328.s11" origId="s11" text="Fenbufen is not approved in the United States at this time."><entity id="DrugDDI.d328.s11.e0" origId="s11.p125" charOffset="0-8" type="drug" text="Fenbufen"/></sentence><sentence id="DrugDDI.d328.s12" origId="s12" text="Sucralfate and antacids: Quinolones form chelates with metal cations."><entity id="DrugDDI.d328.s12.e0" origId="s12.p131" charOffset="0-10" type="drug" text="Sucralfate"/><entity id="DrugDDI.d328.s12.e1" origId="s12.p133" charOffset="15-23" type="drug" text="antacids"/><entity id="DrugDDI.d328.s12.e2" origId="s12.p135" charOffset="25-35" type="drug" text="Quinolones"/><entity id="DrugDDI.d328.s12.e3" origId="s12.p138" charOffset="61-68" type="drug" text="cations"/><pair id="DrugDDI.d328.s12.p0" e1="DrugDDI.d328.s12.e0" e2="DrugDDI.d328.s12.e1" interaction="false"/><pair id="DrugDDI.d328.s12.p1" e1="DrugDDI.d328.s12.e0" e2="DrugDDI.d328.s12.e2" interaction="false"/><pair id="DrugDDI.d328.s12.p2" e1="DrugDDI.d328.s12.e0" e2="DrugDDI.d328.s12.e3" interaction="false"/><pair id="DrugDDI.d328.s12.p3" e1="DrugDDI.d328.s12.e1" e2="DrugDDI.d328.s12.e2" interaction="false"/><pair id="DrugDDI.d328.s12.p4" e1="DrugDDI.d328.s12.e1" e2="DrugDDI.d328.s12.e3" interaction="false"/><pair id="DrugDDI.d328.s12.p5" e1="DrugDDI.d328.s12.e2" e2="DrugDDI.d328.s12.e3" interaction="false"/></sentence><sentence id="DrugDDI.d328.s13" origId="s13" text="Therefore, administration of quinolones with antacids containing calcium, magnesium, or aluminum;"><entity id="DrugDDI.d328.s13.e0" origId="s13.p141" charOffset="29-39" type="drug" text="quinolones"/><entity id="DrugDDI.d328.s13.e1" origId="s13.p142" charOffset="45-53" type="drug" text="antacids"/><entity id="DrugDDI.d328.s13.e2" origId="s13.p144" charOffset="65-72" type="drug" text="calcium"/><entity id="DrugDDI.d328.s13.e3" origId="s13.p145" charOffset="74-83" type="drug" text="magnesium"/><pair id="DrugDDI.d328.s13.p0" e1="DrugDDI.d328.s13.e0" e2="DrugDDI.d328.s13.e1" interaction="false"/><pair id="DrugDDI.d328.s13.p1" e1="DrugDDI.d328.s13.e0" e2="DrugDDI.d328.s13.e2" interaction="false"/><pair id="DrugDDI.d328.s13.p2" e1="DrugDDI.d328.s13.e0" e2="DrugDDI.d328.s13.e3" interaction="false"/><pair id="DrugDDI.d328.s13.p3" e1="DrugDDI.d328.s13.e1" e2="DrugDDI.d328.s13.e2" interaction="false"/><pair id="DrugDDI.d328.s13.p4" e1="DrugDDI.d328.s13.e1" e2="DrugDDI.d328.s13.e3" interaction="false"/><pair id="DrugDDI.d328.s13.p5" e1="DrugDDI.d328.s13.e2" e2="DrugDDI.d328.s13.e3" interaction="false"/></sentence><sentence id="DrugDDI.d328.s14" origId="s14" text="with sucralfate;"><entity id="DrugDDI.d328.s14.e0" origId="s14.p149" charOffset="5-15" type="drug" text="sucralfate"/></sentence><sentence id="DrugDDI.d328.s15" origId="s15" text="with divalent or trivalent cations such as iron;"><entity id="DrugDDI.d328.s15.e0" origId="s15.p153" charOffset="27-34" type="drug" text="cations"/><entity id="DrugDDI.d328.s15.e1" origId="s15.p154" charOffset="43-47" type="drug" text="iron"/><pair id="DrugDDI.d328.s15.p0" e1="DrugDDI.d328.s15.e0" e2="DrugDDI.d328.s15.e1" interaction="false"/></sentence><sentence id="DrugDDI.d328.s16" origId="s16" text="or with multivitamins containing zinc may substantially interfere with drug absorption and result in insufficient plasma and tissue quinolone concentrations."><entity id="DrugDDI.d328.s16.e0" origId="s16.p157" charOffset="8-21" type="drug" text="multivitamins"/><entity id="DrugDDI.d328.s16.e1" origId="s16.p159" charOffset="33-37" type="drug" text="zinc"/><entity id="DrugDDI.d328.s16.e2" origId="s16.p168" charOffset="125-142" type="drug" text="tissue quinolone"/><pair id="DrugDDI.d328.s16.p0" e1="DrugDDI.d328.s16.e0" e2="DrugDDI.d328.s16.e1" interaction="false"/><pair id="DrugDDI.d328.s16.p1" e1="DrugDDI.d328.s16.e0" e2="DrugDDI.d328.s16.e2" interaction="false"/><pair id="DrugDDI.d328.s16.p2" e1="DrugDDI.d328.s16.e1" e2="DrugDDI.d328.s16.e2" interaction="false"/></sentence><sentence id="DrugDDI.d328.s17" origId="s17" text="Antacids containing aluminum hydroxide and magnesium hydroxide reduce the oral absorption of enoxacin by 75%."><entity id="DrugDDI.d328.s17.e0" origId="s17.p169" charOffset="0-8" type="drug" text="Antacids"/><entity id="DrugDDI.d328.s17.e1" origId="s17.p171" charOffset="20-38" type="drug" text="aluminum hydroxide"/><entity id="DrugDDI.d328.s17.e2" origId="s17.p173" charOffset="43-62" type="drug" text="magnesium hydroxide"/><entity id="DrugDDI.d328.s17.e3" origId="s17.p176" charOffset="93-101" type="drug" text="enoxacin"/><pair id="DrugDDI.d328.s17.p0" e1="DrugDDI.d328.s17.e0" e2="DrugDDI.d328.s17.e1" interaction="false"/><pair id="DrugDDI.d328.s17.p1" e1="DrugDDI.d328.s17.e0" e2="DrugDDI.d328.s17.e2" interaction="false"/><pair id="DrugDDI.d328.s17.p2" e1="DrugDDI.d328.s17.e0" e2="DrugDDI.d328.s17.e3" interaction="true"/><pair id="DrugDDI.d328.s17.p3" e1="DrugDDI.d328.s17.e1" e2="DrugDDI.d328.s17.e2" interaction="false"/><pair id="DrugDDI.d328.s17.p4" e1="DrugDDI.d328.s17.e1" e2="DrugDDI.d328.s17.e3" interaction="true"/><pair id="DrugDDI.d328.s17.p5" e1="DrugDDI.d328.s17.e2" e2="DrugDDI.d328.s17.e3" interaction="true"/></sentence><sentence id="DrugDDI.d328.s18" origId="s18" text="The oral bioavailability of enoxacin is reduced by 60% with coadministration of ranitidine."><entity id="DrugDDI.d328.s18.e0" origId="s18.p179" charOffset="28-36" type="drug" text="enoxacin"/><entity id="DrugDDI.d328.s18.e1" origId="s18.p184" charOffset="80-90" type="drug" text="ranitidine"/><pair id="DrugDDI.d328.s18.p0" e1="DrugDDI.d328.s18.e0" e2="DrugDDI.d328.s18.e1" interaction="true"/></sentence><sentence id="DrugDDI.d328.s19" origId="s19" text="These agents should not be taken for 8 hours before or for 2 hours after enoxacin administration."><entity id="DrugDDI.d328.s19.e0" origId="s19.p194" charOffset="73-81" type="drug" text="enoxacin"/></sentence><sentence id="DrugDDI.d328.s20" origId="s20" text="Theophylline: Enoxacin is a potent inhibitor of the cytochrome P-450 isozymes responsible for the metabolism of methylxanthines."><entity id="DrugDDI.d328.s20.e0" origId="s20.p195" charOffset="0-12" type="drug" text="Theophylline"/><entity id="DrugDDI.d328.s20.e1" origId="s20.p197" charOffset="14-22" type="drug" text="Enoxacin"/><entity id="DrugDDI.d328.s20.e2" origId="s20.p200" charOffset="52-68" type="drug" text="cytochrome P-450"/><entity id="DrugDDI.d328.s20.e3" origId="s20.p202" charOffset="112-127" type="drug" text="methylxanthines"/><pair id="DrugDDI.d328.s20.p0" e1="DrugDDI.d328.s20.e0" e2="DrugDDI.d328.s20.e1" interaction="false"/><pair id="DrugDDI.d328.s20.p1" e1="DrugDDI.d328.s20.e0" e2="DrugDDI.d328.s20.e2" interaction="false"/><pair id="DrugDDI.d328.s20.p2" e1="DrugDDI.d328.s20.e0" e2="DrugDDI.d328.s20.e3" interaction="false"/><pair id="DrugDDI.d328.s20.p3" e1="DrugDDI.d328.s20.e1" e2="DrugDDI.d328.s20.e2" interaction="false"/><pair id="DrugDDI.d328.s20.p4" e1="DrugDDI.d328.s20.e1" e2="DrugDDI.d328.s20.e3" interaction="false"/><pair id="DrugDDI.d328.s20.p5" e1="DrugDDI.d328.s20.e2" e2="DrugDDI.d328.s20.e3" interaction="false"/></sentence><sentence id="DrugDDI.d328.s21" origId="s21" text="Enoxacin interferes with the metabolism of theophylline resulting in a 42% to 74% dose-related decrease in theophylline clearance and a subsequent 260% to 350% increase in serum theophylline levels."><entity id="DrugDDI.d328.s21.e0" origId="s21.p203" charOffset="0-8" type="drug" text="Enoxacin"/><entity id="DrugDDI.d328.s21.e1" origId="s21.p206" charOffset="43-55" type="drug" text="theophylline"/><entity id="DrugDDI.d328.s21.e2" origId="s21.p210" charOffset="107-119" type="drug" text="theophylline"/><pair id="DrugDDI.d328.s21.p0" e1="DrugDDI.d328.s21.e0" e2="DrugDDI.d328.s21.e1" interaction="true"/><pair id="DrugDDI.d328.s21.p1" e1="DrugDDI.d328.s21.e0" e2="DrugDDI.d328.s21.e2" interaction="false"/><pair id="DrugDDI.d328.s21.p2" e1="DrugDDI.d328.s21.e1" e2="DrugDDI.d328.s21.e2" interaction="false"/></sentence><sentence id="DrugDDI.d328.s22" origId="s22" text="Theophylline-related adverse effects have occurred in patients when theophylline and enoxacin were coadministered."><entity id="DrugDDI.d328.s22.e0" origId="s22.p215" charOffset="0-12" type="drug" text="Theophylline"/><entity id="DrugDDI.d328.s22.e1" origId="s22.p220" charOffset="68-80" type="drug" text="theophylline"/><entity id="DrugDDI.d328.s22.e2" origId="s22.p222" charOffset="85-93" type="drug" text="enoxacin"/><pair id="DrugDDI.d328.s22.p0" e1="DrugDDI.d328.s22.e0" e2="DrugDDI.d328.s22.e1" interaction="false"/><pair id="DrugDDI.d328.s22.p1" e1="DrugDDI.d328.s22.e0" e2="DrugDDI.d328.s22.e2" interaction="false"/><pair id="DrugDDI.d328.s22.p2" e1="DrugDDI.d328.s22.e1" e2="DrugDDI.d328.s22.e2" interaction="true"/></sentence><sentence id="DrugDDI.d328.s23" origId="s23" text="Warfarin: Quinolones, including enoxacin, decrease the clearance of R-warfarin, the less active isomer of racemic warfarin."><entity id="DrugDDI.d328.s23.e0" origId="s23.p225" charOffset="0-8" type="drug" text="Warfarin"/><entity id="DrugDDI.d328.s23.e1" origId="s23.p227" charOffset="10-20" type="drug" text="Quinolones"/><entity id="DrugDDI.d328.s23.e2" origId="s23.p229" charOffset="32-40" type="drug" text="enoxacin"/><entity id="DrugDDI.d328.s23.e3" origId="s23.p232" charOffset="70-78" type="drug" text="warfarin"/><entity id="DrugDDI.d328.s23.e4" origId="s23.p234" charOffset="114-122" type="drug" text="warfarin"/><pair id="DrugDDI.d328.s23.p0" e1="DrugDDI.d328.s23.e0" e2="DrugDDI.d328.s23.e1" interaction="false"/><pair id="DrugDDI.d328.s23.p1" e1="DrugDDI.d328.s23.e0" e2="DrugDDI.d328.s23.e2" interaction="false"/><pair id="DrugDDI.d328.s23.p2" e1="DrugDDI.d328.s23.e0" e2="DrugDDI.d328.s23.e3" interaction="false"/><pair id="DrugDDI.d328.s23.p3" e1="DrugDDI.d328.s23.e0" e2="DrugDDI.d328.s23.e4" interaction="false"/><pair id="DrugDDI.d328.s23.p4" e1="DrugDDI.d328.s23.e1" e2="DrugDDI.d328.s23.e2" interaction="true"/><pair id="DrugDDI.d328.s23.p5" e1="DrugDDI.d328.s23.e1" e2="DrugDDI.d328.s23.e3" interaction="true"/><pair id="DrugDDI.d328.s23.p6" e1="DrugDDI.d328.s23.e1" e2="DrugDDI.d328.s23.e4" interaction="false"/><pair id="DrugDDI.d328.s23.p7" e1="DrugDDI.d328.s23.e2" e2="DrugDDI.d328.s23.e3" interaction="false"/><pair id="DrugDDI.d328.s23.p8" e1="DrugDDI.d328.s23.e2" e2="DrugDDI.d328.s23.e4" interaction="false"/><pair id="DrugDDI.d328.s23.p9" e1="DrugDDI.d328.s23.e3" e2="DrugDDI.d328.s23.e4" interaction="false"/></sentence><sentence id="DrugDDI.d328.s24" origId="s24" text="Enoxacin does not affect the clearance of the active S-isomer, and changes in clotting time have not been observed when enoxacin and warfarin were coadministered."><entity id="DrugDDI.d328.s24.e0" origId="s24.p235" charOffset="0-8" type="drug" text="Enoxacin"/><entity id="DrugDDI.d328.s24.e1" origId="s24.p249" charOffset="120-128" type="drug" text="enoxacin"/><entity id="DrugDDI.d328.s24.e2" origId="s24.p251" charOffset="133-141" type="drug" text="warfarin"/><pair id="DrugDDI.d328.s24.p0" e1="DrugDDI.d328.s24.e0" e2="DrugDDI.d328.s24.e1" interaction="false"/><pair id="DrugDDI.d328.s24.p1" e1="DrugDDI.d328.s24.e0" e2="DrugDDI.d328.s24.e2" interaction="false"/><pair id="DrugDDI.d328.s24.p2" e1="DrugDDI.d328.s24.e1" e2="DrugDDI.d328.s24.e2" interaction="false"/></sentence><sentence id="DrugDDI.d328.s25" origId="s25" text="Nevertheless, the prothrombin time or other suitable coagulation test should be monitored when warfarin or its derivatives and enoxacin are given concomitantly."><entity id="DrugDDI.d328.s25.e0" origId="s25.p262" charOffset="95-103" type="drug" text="warfarin"/><entity id="DrugDDI.d328.s25.e1" origId="s25.p264" charOffset="111-122" type="drug" text="derivatives"/><entity id="DrugDDI.d328.s25.e2" origId="s25.p266" charOffset="127-135" type="drug" text="enoxacin"/><pair id="DrugDDI.d328.s25.p0" e1="DrugDDI.d328.s25.e0" e2="DrugDDI.d328.s25.e1" interaction="false"/><pair id="DrugDDI.d328.s25.p1" e1="DrugDDI.d328.s25.e0" e2="DrugDDI.d328.s25.e2" interaction="true"/><pair id="DrugDDI.d328.s25.p2" e1="DrugDDI.d328.s25.e1" e2="DrugDDI.d328.s25.e2" interaction="true"/></sentence></document>